We first confirmed cell surface expression of CD19, TRAIL-R1, and TRAIL-R2 on the BCP-ALL cell lines REH and NALM-6 as compared to the T-ALL cell line CEM by quantitative indirect immunofluorescence analyses. This evidence concerns the gene TNFRSF10B and acute lymphoblastic leukemia.